SPIMACO net profit down 53% to SAR 64.6 mln in 9M 2021

04/11/2021 Argaam Exclusive

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) reported a net profit after Zakat and tax of SAR 64.6 million for the first nine months of 2021, a 53% decline from SAR 138 million in the same period last year.

 

The company attributed the decrease in net profit to lower sales due to the recall of two of the company's products from the local and export markets for conducting new bioequivalence studies.

 



Financials (M)

Item 9m 2020 9m 2021 Change‬
Revenues 1,176.77 1,092.12 (7.2 %)
Gross Income 544.93 461.21 (15.4 %)
Operating Income 140.31 68.42 (51.2 %)
Net Income 137.99 64.61 (53.2 %)
Average Shares 120.00 120.00 -
EPS (Riyals) 1.15 0.54 (53.2 %)

The company reported a net profit of SAR 7.40 million for Q3 2021, a plunge of 89% year-on-year (YoY).

 

On a sequential basis, net profit fell 76.2% from SAR 31.07 million on lower sales due to the seasonal effect in demand level.



Current Quarter Comparison (M)

Compared With The
Item Q3 2020 Q3 2021 Change‬
Revenues 372.91 311.36 (16.5 %)
Gross Income 195.71 145.71 (25.5 %)
Operating Income 70.05 18.69 (73.3 %)
Net Income 67.41 7.40 (89.0 %)
Average Shares 120.00 120.00 -
EPS (Riyals) 0.56 0.06 (89.0 %)

Shareholders’ equity, after minority interest, dropped to SAR 1.863 billion as of Sept. 30, 2021, from SAR 1.911 billion a year earlier.

 

View more financial results

 

View other reports

Share Price

Saudi Pharmaceutical Industries and Medical Appliances Corp.
32.70
(0.20) (0.61 %)

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO)

More


Financial Ratios
Current
Market Cap (M Riyal) 3,924.00
Enterprise Value (EV) (M) 5,193.60
Shares Outstanding ((M)) 120.00
EPS ( Riyal) (TTM) (0.18)
Book Value (BV) ( Riyal) 12.35
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) Neg
P/E (TTM) NEG
Price/book 2.65
Return on Average Assets (%) (TTM) (0.51 )
Return on Average Equity (%) (TTM) (1.46 )
more

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2024, Argaam Investment, All Rights Reserved
Call Request